SNAP25 and Alzheimer disease: This result is in agreement with an earlier study suggesting that the longer soluble forms of soluble SNAP-25, including the Ac-2-47 form targeted by both the Simoa and the IP-MS assays, provide the best differential diagnostic SNAP-25 biomarker of AD compared to controls [5].